Tufton Capital Management Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Tufton Capital Management lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 973 shares of the medical equipment provider’s stock after selling 35 shares during the period. Tufton Capital Management’s holdings in Intuitive Surgical were worth $508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department acquired a new stake in Intuitive Surgical during the fourth quarter valued at $28,000. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter valued at $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter valued at $36,000. Finally, Sierra Ocean LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at $40,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research report on Thursday, December 5th. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Piper Sandler reiterated an “overweight” rating and issued a $670.00 target price (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at $208,181.75. This trade represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,077 shares of company stock valued at $4,620,025 over the last ninety days. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $563.77 on Friday. The firm’s 50-day moving average is $568.89 and its two-hundred day moving average is $527.90. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $200.80 billion, a PE ratio of 87.95, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.